Concord Biotech Ltd

Concord Biotech Q1 FY25 Results: Key Insights & Outlook 📊

- Concord Biotech will discuss unaudited standalone and consolidated financial results for Q1 ended June 30, 2025.

- The earnings call is scheduled for August 11, 2025, at 04:00 PM IST.

- Key participants include Mr. Sudhir Vaid (Chairman & MD), Mr. Ankur Vaid (Joint MD & CEO), Mr. Lalit Sethi (CFO), and Mr. Prakash Sajnani (AVP - Accounts & Finance).

- Discussion topics: Operational performance, financial results, and future outlook.